Going off-label without venturing off-course: evidence and ethical off-label prescribing

Arch Intern Med. 2009 Oct 26;169(19):1745-7. doi: 10.1001/archinternmed.2009.314.

Authors

Emily A Largent¹, Franklin G Miller, Steven D Pearson

Affiliation

¹ Clinical Center Department of Ethics, National Institutes of Health, Bethesda, MD 20892-1156, USA.

PMID: 19858430
DOI: 10.1001/archinternmed.2009.314

No abstract available

MeSH terms

Communication
Drug Costs
Drug Labeling*
Drug Prescriptions / standards*
Drug-Related Side Effects and Adverse Reactions*
Ethics, Clinical
Evidence-Based Medicine
Humans
Informed Consent
Practice Patterns, Physicians' / ethics*
Practice Patterns, Physicians' / standards
United States
United States Food and Drug Administration